Jooho Park

发表

Functionalized heparin-protamine based self-assembled nanocomplex for efficient anti-angiogenic therapy.

Seung Woo Chung, D. S. Lee, Y. Byun, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Self-assembled nanocomplex of PEGylated protamine and heparin-suramin conjugate for accumulation at the tumor site.

Y. Byun, S. Hwang, F. Alam, 2018, International journal of pharmaceutics.

Bile acid transporter mediated endocytosis of oral bile acid conjugated nanocomplex.

Kwangmeyung Kim, Y. Byun, J. U. Choi, 2017, Biomaterials.

Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment

I. Kwon, W. Um, J. Ryu, 2019, Theranostics.

Functional transformations of bile acid transporters induced by high-affinity macromolecules

Seung Woo Chung, Kwangmeyung Kim, Y. Byun, 2014, Scientific reports.

Dual mechanistic TRAIL nanocarrier based on PEGylated heparin taurocholate and protamine which exerts both pro-apoptotic and anti-angiogenic effects.

Seung Woo Chung, Y. Byun, Ji-Young Kim, 2021, Journal of controlled release : official journal of the Controlled Release Society.

Visible light-induced apoptosis activatable nanoparticles of photosensitizer-DEVD-anticancer drug conjugate for targeted cancer therapy.

Kwangmeyung Kim, Y. Byun, I. Kwon, 2019, Biomaterials.

Size Controlled Heparin Fragment-Deoxycholic Acid Conjugate Showed Anticancer Property by Inhibiting VEGF165.

Y. Byun, Ji-Young Kim, Jee‐Heon Jeong, 2015, Bioconjugate chemistry.

Targeting of claudin-4 by Clostridium perfringens enterotoxin-conjugated polysialic acid nanoparticles for pancreatic cancer therapy.

Jong-Ho Kim, J. Na, Sangmin Lee, 2021, Journal of controlled release : official journal of the Controlled Release Society.

Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate).

Y. Byun, In‐San Kim, S. Y. Kim, 2016, Biomaterials.

Cinobufagin Suppresses Melanoma Cell Growth by Inhibiting LEF1

T. Kang, Ji-Hong Lim, Jooho Park, 2020, International journal of molecular sciences.

Current Limitations and Recent Progress in Nanomedicine for Clinically Available Photodynamic Therapy

I. Park, Yong-kyu Lee, S. Hwang, 2021, Biomedicines.

A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway.

Seung Woo Chung, Y. Byun, S. Y. Kim, 2017, Biomaterials.

Oral pemetrexed facilitates low‐dose metronomic therapy and enhances antitumor efficacy in lung cancer

D. S. Lee, Y. Byun, F. Alam, 2018, Journal of controlled release : official journal of the Controlled Release Society.

A Comparative Study on Albumin-binding Molecules for Targeted Tumor Delivery through Covalent and Noncovalent Approach.

Kwangmeyung Kim, J. Park, W. Um, 2019, Bioconjugate chemistry.

Terminal alkyl substitution in an A–D–A-type nonfullerene acceptor: simultaneous improvements in the open-circuit voltage and short-circuit current for efficient indoor power generation

Bumjoon J. Kim, J. Shim, T. Shin, 2020 .

Heparin and Its Derivatives: Challenges and Advances in Therapeutic Biomolecules

T. Kang, Ji-Hong Lim, Jooho Park, 2021, International journal of molecular sciences.

Combinational chemoprevention effect of celecoxib and an oral antiangiogenic LHD4 on colorectal carcinogenesis in mice

Seung Woo Chung, Y. Byun, Ji-Young Kim, 2014, Anti-cancer drugs.

Peptide-Based Bioconjugates and Therapeutics for Targeted Anticancer Therapy

Jooho Park, Nipa Banik, Seong-Bin Yang, 2022, Pharmaceutics.

Chemical Conjugate of Low Molecular Weight Heparin and Suramin Fragment Inhibits Tumor Growth Possibly by Blocking VEGF165.

Y. Byun, Ji-Young Kim, S. Hwang, 2015, Molecular pharmaceutics.

Metronomic dose-finding approach in oral chemotherapy by experimentally-driven integrative mathematical modeling.

Seung Woo Chung, Y. Byun, Yoo-Seong Jeong, 2022, Biomaterials.

Senotherapeutics and Their Molecular Mechanism for Improving Aging

D. Shin, Jooho Park, 2022, Biomolecules & therapeutics.

Catalase-mimicking synthetic nano-enzymes can reduce lipopolysaccharide-induced reactive oxygen generation and promote rapid detection of hydrogen peroxide and l-cysteine

J. Mondal, I. Park, Santhosh Kalash Rajendrakumar, 2022, Journal of Pharmaceutical Investigation.

Tumor vasculature targeting following co-delivery of heparin-taurocholate conjugate and suberoylanilide hydroxamic acid using cationic nanolipoplex.

Seung Woo Chung, Kwangmeyung Kim, Y. Byun, 2012, Biomaterials.

Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity

Kwangmeyung Kim, M. Shim, Jooho Park, 2022, Journal of Nanobiotechnology.

Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity.

Kwangmeyung Kim, In‐San Kim, Yoon Park, 2021, Biomaterials.

End-Site-Specific Conjugation of Enoxaparin and Tetradeoxycholic Acid Using Nonenzymatic Glycosylation for Oral Delivery.

Kwangmeyung Kim, Y. Byun, Jinha Hwang, 2016, Journal of medicinal chemistry.

The Molecular Mechanism of Polyphenols with Anti-Aging Activity in Aged Human Dermal Fibroblasts

D. Shin, Jooho Park, Joohee Lee, 2022, Molecules.

NLRP3 Ubiquitination—A New Approach to Target NLRP3 Inflammasome Activation

T. Kang, Jooho Park, Md. Ezazul Haque, 2021, International journal of molecular sciences.

Caspase-3/-7-Specific Metabolic Precursor for Bioorthogonal Tracking of Tumor Apoptosis

Kwangmeyung Kim, I. Kwon, Jong‐Ho Kim, 2017, Scientific Reports.

Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy.

Kwangmeyung Kim, Y. Byun, I. Kwon, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Preliminary safety evaluation of a taurocholate‐conjugated low‐molecular‐weight heparin derivative (LHT7): a potent angiogenesis inhibitor

Seung Woo Chung, Y. Byun, Ji-Young Kim, 2015, Journal of applied toxicology : JAT.

Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy

Kwangmeyung Kim, W. Um, J. Ryu, 2019, Theranostics.

Recent advances in anticoagulant drug delivery

Y. Byun, Jooho Park, 2016, Expert opinion on drug delivery.

Regulation of Caspase-8 Activity at the Crossroads of Pro-Inflammation and Anti-Inflammation

T. Kang, Jun-Hyuk Han, Jooho Park, 2021, International journal of molecular sciences.

Dual-Modal Imaging-Guided Precise Tracking of Bioorthogonally Labeled Mesenchymal Stem Cells in Mouse Brain Stroke.

Kwangmeyung Kim, Dong-Eog Kim, H. Y. Yoon, 2019, ACS nano.

Nano-sized metabolic precursors for heterogeneous tumor-targeting strategy using bioorthogonal click chemistry in vivo.

C. Ahn, M. Pomper, Kwangmeyung Kim, 2017, Biomaterials.

Targeting prion-like protein doppel selectively suppresses tumor angiogenesis.

Seung Woo Chung, Y. Byun, In‐San Kim, 2016, The Journal of clinical investigation.

Properties of Heparinoids Premixed with Tumor-Derived Extracellular Vesicles.

Y. Byun, Jun-Pil Jee, S. Hwang, 2018, Bioconjugate chemistry.

Epidermal growth factor (EGF)-based activatable probe for predicting therapeutic outcome of an EGF-based doxorubicin prodrug.

Eun Sun Kim, Kwangmeyung Kim, I. Kwon, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Advances in Radionuclides and Radiolabelled Peptides for Cancer Therapeutics

J. Mondal, Yong-kyu Lee, Jooho Park, 2023, Pharmaceutics.

Cyclic RGDyk-conjugated LMWH-taurocholate derivative as a targeting angiogenesis inhibitor.

Seung Woo Chung, Y. Byun, Ji-Young Kim, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Design, Synthesis, and Therapeutic Evaluation of Poly(acrylic acid)-tetraDOCA Conjugate as a Bile Acid Transporter Inhibitor.

Y. Byun, Jee‐Heon Jeong, T. Al-Hilal, 2015, Bioconjugate chemistry.

Extracellular production of an anti-HER2 single-chain variable antibody fragment in Escherichia coli

T. Kang, H. Won, Jae-Won Hyun, 2021, Process Biochemistry.

Oligomeric bile acid-mediated oral delivery of low molecular weight heparin.

Seung Woo Chung, Kwangmeyung Kim, Y. Byun, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Immunomodulation effect of mesenchymal stem cells in islet transplantation.

S. Yook, Tiep Tien Nguyen, J. U. Choi, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Potentiation of anti-angiogenic activity of heparin by blocking the ATIII-interacting pentasaccharide unit and increasing net anionic charge.

Beom Suk Lee, Seung Woo Chung, Y. Byun, 2012, Biomaterials.

Development of a Peptide-Based Nano-Sized Cathepsin B Inhibitor for Anticancer Therapy

T. Kang, Jooho Park, Seong-Bin Yang, 2023, Pharmaceutics.

Non-invasive in vivo imaging of caspase-1 activation enables rapid and spatiotemporal detection of acute and chronic inflammatory disorders.

Y. Jeon, Nam-Hyuk Cho, Ick Chan Kwon, 2020, Biomaterials.

Molecular Targeting of VEGF with a Suramin Fragment–DOCA Conjugate by Mimicking the Action of Low Molecular Weight Heparins

T. Kang, H. Won, Jooho Park, 2020, Biomolecules.

An amphiphilic material arginine-arginine-bile acid promotes α-synuclein amyloid formation.

J. Kardos, Sungsu Lim, Jaekwang Kim, 2023, Nanoscale.

A Trojan-Horse Strategy by In Situ Piggybacking onto Endogenous Albumin for Tumor-Specific Neutralization of Oncogenic MicroRNA.

Sun Hwa Kim, Yoosoo Yang, Ick Chan Kwon, 2021, ACS nano.

Functional transformations of bile acid transporters induced by high-affinity macromolecules

Seung Woo Chung, Kwangmeyung Kim, Y. Byun, 2014, Scientific reports.

Functional transformations of bile acid transporters induced by high-affinity

Seung Woo Chung, Y. Byun, F. Alam, 2014 .

Doxorubicin covalently conjugated heparin displays anti-cancer activity as a self-assembled nanoparticle with a low-anticoagulant effect.

Young Jun Kim, Jooho Park, Seong-Bin Yang, 2023, Carbohydrate polymers.

Design and Evaluation of a Carrier-Free Prodrug-Based Palmitic-DEVD-Doxorubicin Conjugate for Targeted Cancer Therapy.

Jooho Park, Young-Ho Lee, Seong-Bin Yang, 2023, Bioconjugate chemistry.

Caspase-3/-7-Specific Metabolic Precursor for Bioorthogonal Tracking of Tumor Apoptosis

Kwangmeyung Kim, I. Kwon, Jong‐Ho Kim, 2017, Scientific Reports.

Design of chimeric GLP-1A using oligomeric bile acids to utilize transporter-mediated endocytosis for oral delivery

Jin-woo Park, Y. Byun, J. Shim, 2023, Biomaterials Research.